Trial lecture and disputation October 27-28th
Kristine Gulliksrud
Siv. ing. Kristine Gulliksrud from Einar Rofstad's group at the Department of Radiation Biology at the Institute for Cancer Research will give her trial lectures on Thursday October 27th. The lecture over the subject of her own choice - "Assessment of tumor pH by magnetic resonance spectroscopy and imaging" starts at 14:15. The given subject is "Therapeutic approaches for dealing with the hypoxia problem", and this lecture begins at 15:15. Both trial lectures take place in the Auditorium in the Research Therapy Building at the OUS-Radiumhospitalet, Montebello. She will defend her PhD thesis - entitled "DCE-MRI in assessment of the microenvironment and aggressiveness of human tumor xenografts" the following day, on Friday October 28th at 10:15. The disputation takes place in the "Lille Fysiske auditorium, Fysikkbygningen" at the University of Oslo.
From major journals, first or last author from the Institute for Cancer Research
Bischof K, Cremaschi A, Eroukhmanoff L, Landskron J, Flage-Larsen LL, Gade A, Bjørge L, Urbanucci A, Taskén K(2024) Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways Mol Oncol(in press) DOI 10.1002/1878-0261.13726, PubMed 39245677
Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH(2024) Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma Blood Cancer J, 14(1), 147 DOI 10.1038/s41408-024-01124-5, PubMed 39191762
Llorente A, Brokāne A, Mlynska A, Puurand M, Sagini K, Folkmane S, Hjorth M, Martin-Gracia B, Romero S, Skorinkina D, Čampa M, Cešeiko R, Romanchikova N, Kļaviņa A, Käämbre T, Linē A(2024) From sweat to hope: The role of exercise-induced extracellular vesicles in cancer prevention and treatment J Extracell Vesicles, 13(8), e12500 DOI 10.1002/jev2.12500, PubMed 39183543
Bischof K, Cremaschi A, Eroukhmanoff L, Landskron J, Flage-Larsen LL, Gade A, Bjørge L, Urbanucci A, Taskén K(2024) Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways Mol Oncol(in press) DOI 10.1002/1878-0261.13726, PubMed 39245677
Davidson B, Teien Lande K, Nebdal D, Nesbakken AJ, Holth A, Lindemann K, Zahl Eriksson AG, Sørlie T(2024) Endometrial carcinomas with ambiguous histology often harbor TP53 mutations Virchows Arch(in press) DOI 10.1007/s00428-024-03912-7, PubMed 39235515
Skånland SS, Okkenhaug K, Davids MS(2024) PI3K Inhibitors in Hematology: When One Door Closes… Clin Cancer Res, 30(17), 3667-3675 DOI 10.1158/1078-0432.CCR-24-0967, PubMed 38967552